SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140705-18-000378
Filing Date
2018-11-19
Accepted
2018-11-19 13:50:21
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q iaso_10q.htm 10-Q 388635
2 CERTIFICATION exhibit31_1.htm EX-31.1 14524
3 CERTIFICATION exhibit31_2.htm EX-31.2 14599
4 CERTIFICATION exhibit32_1.htm EX-32.1 9344
  Complete submission text file 0001140705-18-000378.txt   1651094

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT iaso-20180930_cal.xml EX-101.CAL 16197
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iaso-20180930_def.xml EX-101.DEF 50456
7 XBRL INSTANCE DOCUMENT iaso-20180930.xml EX-101.INS 184231
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT iaso-20180930_lab.xml EX-101.LAB 123140
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iaso-20180930_pre.xml EX-101.PRE 112055
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iaso-20180930.xsd EX-101.SCH 32200
Mailing Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111
Business Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111 (303) 796-8940
IASO BioMed, Inc. (Filer) CIK: 0001662907 (see all company filings)

IRS No.: 473474169 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-215083 | Film No.: 181192036
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1